Inhibition of human glutamine synthetase by L-methionine-S,R-sulfoximine—relevance to the treatment of neurological diseases

Metabolic Brain Disease

Volumn 29, Issue 4, 2014, Pages 983-989

  Jeitner, Thomas M ^a   Cooper, Arthur J L ^b  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Amyotrophic lateral sclerosis; Glutamine synthetase; Hyperammonemia; L methionine S,R sulfoximine

Indexed keywords

ADENOSINE TRIPHOSPHATE; BACTERIAL PROTEIN; CONVULSANT AGENT; ENZYME INHIBITOR; GLUTAMATE AMMONIA LIGASE; HYBRID PROTEIN; METHIONINE SULFOXIMINE; NERVE PROTEIN; PROTEIN BINDING; SACCHAROMYCES CEREVISIAE PROTEIN; VEGETABLE PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL; ANTAGONISTS AND INHIBITORS; COMPARATIVE STUDY; DOG; DRUG EFFECTS; ENZYMOLOGY; HUMAN; KINETICS; METABOLISM; NERVOUS SYSTEM DISEASES; SHEEP; SPECIES DIFFERENCE;

ADENOSINE TRIPHOSPHATE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BACTERIAL PROTEINS; CONVULSANTS; DOGS; ENZYME INHIBITORS; GLUTAMATE-AMMONIA LIGASE; HUMANS; KINETICS; METHIONINE SULFOXIMINE; NERVE TISSUE PROTEINS; NERVOUS SYSTEM DISEASES; PLANT PROTEINS; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS; SHEEP; SPECIES SPECIFICITY;

EID: 84910668079     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-013-9439-6     Document Type: Article

References (71)

1. Acaster MA, Weitzman PDJ (1985) Kinetic analysis of glutamine synthetases from various plants. FEBS Lett 189(2):241–244
2. Alibhai M, Villafranca JJ (1994) Kinetic and mutagenic studies of the role of the active site residues Asp-50 and Glu-327 of Escherichia coli glutamine synthetase. Biochemistry 33:682–686
3. Bame M, Pentiak PA, Needleman R, Brusilow WS (2012) Effect of sex on lifespan, disease progression, and the response to methionine sulfoximine in the SOD1 G93A mouse model for ALS. Gend Med 9:524–535
4. Bensimon G, Doble A (2004) The tolerability of riluzole in the treatment of patients with amyotrophic lateral sclerosis. Expert Opin Drug Saf 3:525–534
5. Blanco F, Alana A, Llama MJ, Serra JL (1989) Purification and properties of glutamine synthetase from the non-N2-fixing cyanobacterium Phormidium laminosum. J Bacteriol 171:1158–1165
6. Blin M, Crusio WE, Hevor T, Cloix JF (2002) Chronic inhibition of glutamine synthetase is not associated with impairment of learning and memory in mice. Brain Res Bull 57:11–15
7. Boissonnet A, Hevor T, Cloix JF (2012) Phenotypic differences between fast and slow methionine sulfoximine-inbred mice: seizures, anxiety, and glutamine synthetase. Epilepsy Res 98:25–34
8. Boissonnet A, Hevor T, Landemarre L, Cloix JF (2013) Monoamines and glycogen levels in cerebral cortices of fast and slow methionine sulfoximine-inbred mice. Epilepsy Res 104:217–225
9. Brusilow SW, Koehler RC, Traystman RJ, Cooper AJL (2010) Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy. Neurotherapeutics 7:452–470
10. Carroll P, Waddell SJ, Butcher PD, Parish T (2011) Methionine sulfoximine resistance in Mycobacterium tuberculosis is due to a single nucleotide deletion resulting in increased expression of the major glutamine synthetase, GlnA1. Microb Drug Resist 17:351–355
11. Chang ML, Klaidman LK, Adams JD Jr (1997) The effects of oxidative stress on in vivo brain GSH turnover in young and mature mice. Mol Chem Neuropathol 30:187–197
12. Cooper AJL (2012a) Possible treatment of end-stage hyperammonemic encephalopathy by inhibition of glutamine synthetase. Metab Brain Dis 28:19–25
13. Cooper AJL (2012b) The role of glutamine synthetase and glutamate dehydrogenase in cerebral ammonia homeostasis. Neurochem Res 37:2439–2455
14. Cudalbu C, Lanz B, Duarte JM, Morgenthaler FD, Pilloud Y, Mlynarik V, Gruetter R (2012) Cerebral glutamine metabolism under hyperammonemia determined in vivo by localized (1)H and (15)N NMR spectroscopy. J Cereb Blood Flow Metab 32:696–708
15. Desjardins P, Rao KV, Michalak A, Rose C, Butterworth RF (1999) Effect of portacaval anastomosis on glutamine synthetase protein and gene expression in brain, liver and skeletal muscle. Metab Brain Dis 14:273–280
16. Eisenberg D, Gill HS, Pfluegl GM, Rotstein SH (2000) Structure-function relationships of glutamine synthetases. Biochim Biophys Acta 1477:122–145
17. Franklin CC, Backos DS, Mohar I, White CC, Forman HJ, Kavanagh TJ (2009) Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase. Mol Aspects Med 30:86–98
18. Gershoff SN, Elvehjem CA (1951) The relative effect of methionine sulfoximine on different animal species. J Nutr 45:451–458
19. Ghittoni NE, Ohlsson WG, Sellinger OZ (1970) The effect of methionine on the regional and intracellular disposition of [3H]-methionine sulphoximine in rat brain. J Neurochem 17:1057–1068
20. Ghoddoussi F, Galloway MP, Jambekar A, Bame M, Needleman R, Brusilow WS (2010) Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS. J Neurol Sci 290:41–47
21. Gill HS, Eisenberg D (2001) The crystal structure of phosphinothricin in the active site of glutamine synthetase illuminates the mechanism of enzymatic inhibition. Biochemistry 40:1903–1912
22. Griffith OW, Meister A (1978) Differential inhibition of glutamine and gamma-glutamylcysteine synthetases by alpha-alkyl analogs of methionine sulfoximine that induce convulsions. J Biol Chem 253:2333–2338
23. Hardiman O, van den Berg LH, Kiernan MC (2011) Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol 7:639–649
24. Harth G, Horwitz MA (1999) An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets. J Exp Med 189:1425–1436
25. Harth G, Horwitz MA (2003) Inhibition of Mycobacterium tuberculosis glutamine synthetase as a novel antibiotic strategy against tuberculosis: demonstration of efficacy in vivo. Infect Immun 71:456–464
26. Jambekar AA, Palma E, Nicolosi L, Rasola A, Petronilli V, Chiara F, Bernardi P, Needleman R, Brusilow WS (2011) A glutamine synthetase inhibitor increases survival and decreases cytokine response in a mouse model of acute liver failure. Liver Int 31:1209–1221
27. Jeitner TM, Lawrence DA (2001) Mechanisms for the cytotoxicity of cysteamine. Toxicol Sci 63:57–64
28. Kim KH, Rhee SG (1987) Subunit interaction elicited by partial inactivation with L-methionine sulfoximine and ATP differently affects the biosynthetic and gamma-glutamyltransferase reactions catalyzed by yeast glutamine synthetase. J Biol Chem 262:13050–13054
29. Kingdon HS, Hubbard JS, Stadtman ER (1968) Regulation of glutamine synthetase. XI. The nature and implications of a lag phase in the Escherichia coli glutamine synthetase reaction. Biochemistry 7:2136–2142
30. Knight TJ, Langston-Unkefer PJ (1988) Adenine nucleotides as allosteric effectors of pea seed glutamine synthetase. J Biol Chem 263:11084–11089
31. Krajewski WW, Jones TA, Mowbray SL (2005) Structure of Mycobacterium tuberculosis glutamine synthetase in complex with a transition-state mimic provides functional insights. Proc Natl Acad Sci U S A 102:10499–10504
32. Krajewski WW, Collins R, Holmberg-Schiavone L, Jones TA, Karlberg T, Mowbray SL (2008) Crystal structures of mammalian glutamine synthetases illustrate substrate-induced conformational changes and provide opportunities for drug and herbicide design. J Mol Biol 375:217–228
33. Krakoff IH (1961) Effect of methionine sulfoximine in man. Clin Pharmacol Ther 2:599–604
34. Kruchkova Y, Ben-Dror I, Herschkovitz A, David M, Yayon A, Vardimon L (2001) Basic fibroblast growth factor: a potential inhibitor of glutamine synthetase expression in injured neural tissue. J Neurochem 77:1641–1649
35. Laake JH, Slyngstad TA, Haug FM, Ottersen OP (1995) Glutamine from glial cells is essential for the maintenance of the nerve terminal pool of glutamate: immunogold evidence from hippocampal slice cultures. J Neurochem 65:871–881
36. Lea PJ, Ridley SM (1989) Glutamine synthetase and its inhibition. In: Dodge AD (ed) Herbicides and plant metabolism. Society for experimental biology. Cambridge University Press, Cambridge, pp 137–170
37. Leason M, Cunliffe D, Parkin D, Lea PJ, Miflin BM (1982) Inhibition of pea leaf glutamine synthetase by methionine sulphoximine, phosphinothricin and other glutamate analogues. Phytochemistry 21:855–857
38. Liaw SH, Pan C, Eisenberg D (1993) Feedback inhibition of fully unadenylylated glutamine synthetase from Salmonella typhimurium by glycine, alanine, and serine. Proc Natl Acad Sci U S A 90:4996–5000
39. Liaw SH, Jun G, Eisenberg D (1994) Interactions of nucleotides with fully unadenylylated glutamine synthetase from Salmonella typhimurium. Biochemistry 33:11184–11188
40. Listrom CD, Morizono H, Rajagopal BS, McCann MT, Tuchman M, Allewell NM (1997) Expression, purification, and characterization of recombinant human glutamine synthetase. Biochem J 328(Pt1):159–163
41. Logusch EW, Walker DM, McDonald JF, Franz JE (1989) Substrate variability as a factor in enzyme inhibitor design: inhibition of ovine brain glutamine synthetase by alpha- and gamma-substituted phosphinothricins. Biochemistry 28:3043–3051
42. Manning JM, Moore S, Rowe WB, Meister A (1969) Identification of L-methionine S-sulfoximine as the diastereoisomer of L-methionine SR-sulfoximine that inhibits glutamine synthetase. Biochemistry 8:2681–2685
43. Mardini H, Smith FE, Record CO, Blamire AM (2011) Magnetic resonance quantification of water and metabolites in the brain of cirrhotics following induced hyperammonaemia. J Hepatol 54:1154–1160
44. Martinez-Hernandez A, Bell KP, Norenberg MD (1977) Glutamine synthetase: glial localization in brain. Science 195:1356–1358
45. Maurizi MR, Ginsburg A (1982) Reactivation of glutamine synthetase from Escherichia coli after auto-inactivation with L-methionine-S-sulfoximine, ATP, and Mn2+. J Biol Chem 257:4271–4278
46. Meister A (1980) Catalytic mechanism of glutamine synthetase: overview of glutamine metabolism. Glutamine Metabolism, Enzymology, Regulation 1–40
47. Mellanby E (1946) Diet and canine hysteria; experimental production by treated flour. Br Med J 2:885–887
48. Newell GW, Erickson TC et al (1949) Studies on human subjects receiving highly agenized food materials. J Lab Clin Med 34:239–245
49. Nilsson MT, Krajewski WW, Yellagunda S, Prabhumurthy S, Chamarahally GN, Siddamadappa C, Srinivasa BR, Yahiaoui S, Larhed M, Karlen A, Jones TA, Mowbray SL (2009) Structural basis for the inhibition of Mycobacterium tuberculosis glutamine synthetase by novel ATP-competitive inhibitors. J Mol Biol 393:504–513
50. Norenberg MD, Martinez-Hernandez A (1979) Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res 161:303–310
51. Palekar AG, Tate SS, Meister A (1975) Decrease in glutathione levels of kidney and liver after injection of methionine sulfoximine into rats. Biochem Biophys Res Commun 62:651–657
52. Pamiljans V, Krishnaswamy PR, Dumville G, Meister A (1962) Studies on the mechanism of glutamine synthesis; isolation and properties of the enzyme from sheep brain. Biochemistry 1:153–158
53. Pollock GH (1949) Species specificity of agene toxicity. J Appl Physiol 1:802–806
54. Pow DV, Robinson SR (1994) Glutamate in some retinal neurons is derived solely from glia. Neuroscience 60:355–366
55. Proler ML, Kellaway P (1965) Behavioral and convulsive phenomena induced in the cat by methionine sulfoximine. Ablation and electrographic studies. Neurology 15:931–940
56. Rhee SG, Chock PB, Wedler FC, Sugiyama Y (1981) Subunit interaction in unadenylylated glutamine synthetase from Escherichia coli. Evidence from methionine sulfoximine inhibition studies. J Biol Chem 256:644–648
57. Richman PG, Orlowski M, Meister A (1973) Inhibition of gamma-glutamylcysteine synthetase by L-methionine-S-sulfoximine. J Biol Chem 248:6684–6690
58. Rowe WB, Meister A (1970) Identification of L-methionine-S-sulfoximine as the convulsant isomer of methionine sulfoximine. Proc Natl Acad Sci U S A 66:500–506
59. Sellinger OZ (1967) Inactivation of cerebral glutamine synthetase by DL-methionine-DL-sulfoximine. Biochim Biophys Acta 132:514–516
60. Shin D, Park C (2004) N-terminal extension of canine glutamine synthetase created by splicing alters its enzymatic property. J Biol Chem 279:1184–1190
61. Somers DL, Beckstead RM (1990) Chronic methionine sulfoximine administration reduces synaptosomal aspartate and glutamate in rat striatum. Neurosci Lett 115:335–340
62. Sun HL, Zhang SH, Zhong K, Xu ZH, Feng B, Yu J, Fang Q, Wang S, Wu DC, Zhang JM, Chen Z (2013) A transient upregulation of glutamine synthetase in the dentate gyrus is involved in epileptogenesis induced by amygdala kindling in the rat. PLoS One 8:e66885
63. Tate SS, Leu FY, Meister A (1972) Rat liver glutamine synthetase. Preparation, properties, and mechanism of inhibition by carbamyl phosphate. J Biol Chem 247:5312–5321
64. Tok CY, Chew SF, Peh WY, Loong AM, Wong WP, Ip YK (2009) Glutamine accumulation and up-regulation of glutamine synthetase activity in the swamp eel, Monopterus albus (Zuiew), exposed to brackish water. J Exp Biol 212:1248–1258
65. Tsuda Y, Stephani RA, Meister A (1971) Direct evidence for the formation of an acyl phosphate by glutamine synthetase. Biochemistry 10:3186–3189
66. Unno H, Uchida T, Sugawara H, Kurisu G, Sugiyama T, Yamaya T, Sakakibara H, Hase T, Kusunoki M (2006) Atomic structure of plant glutamine synthetase: a key enzyme for plant productivity. J Biol Chem 281:29287–29296
67. van Rooyen JM, Abratt VR, Belrhali H, Sewell T (2011) Crystal structure of Type III glutamine synthetase: surprising reversal of the inter-ring interface. Structure 19:471–483
68. Villafranca JJ, Ash DE, Wedler FC (1976) Manganese (II) and substrate interaction with unadenylylated glutamine synthetase (Escherichia coli w). II. Electron paramagnetic resonance and nuclear magnetic resonance studies of enzyme-bound manganese(II) with substrates and a potential transition-state analogue, methionine sulfoximine. Biochemistry 15:544–553
69. Warren KS, Schenker S (1964) Effect of an inhibitor of glutamine synthesis (Methionine Sulfoximine) on ammonia toxicity and metabolism. J Lab Clin Med 64:442–449
70. Wedler FC, Horn BR (1976) Catalytic mechanisms of glutamine synthetase enzymes. Studies with analogs of possible intermediates and transition states. J Biol Chem 251:7530–7538
71. Zou J, Wang YX, Dou FF, Lu HZ, Ma ZW, Lu PH, Xu XM (2010) Glutamine synthetase down-regulation reduces astrocyte protection against glutamate excitotoxicity to neurons. Neurochem Int 56:577–584